Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms.
about
Pathophysiology and preventive strategies of anthracycline-induced cardiotoxicityThe Crossroads of Geriatric Cardiology and Cardio-OncologyAnthracycline- and trastuzumab-induced cardiotoxicity: a retrospective studyMetabolic history impacts mammary tumor epithelial hierarchy and early drug response in mice.Altered expression of c-kit and nanog in a rat model of Adriamycin-induced chronic heart failure.WIP1 phosphatase as pharmacological target in cancer therapy.High Throughput Screening Identifies a Novel Compound Protecting Cardiomyocytes from Doxorubicin-Induced DamageObesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-Analysis.Can ErbB2 overexpression protect against doxorubicin cardiotoxicity?Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes.Pharmacogenetics of anthracyclines.Trastuzumab cardiotoxicity: from clinical trials to experimental studies.Exome array analysis identifies ETFB as a novel susceptibility gene for anthracycline-induced cardiotoxicity in cancer patients.Serum biomarkers evaluation to predict chemotherapy-induced cardiotoxicity in breast cancer patients.Inhibition of WIP1 phosphatase sensitizes breast cancer cells to genotoxic stress and to MDM2 antagonist nutlin-3.Dual-Cross-Linked Methacrylated Alginate Sub-Microspheres for Intracellular Chemotherapeutic Delivery.Protective effect of Co-enzyme Q10 On doxorubicin-induced cardiomyopathy of rat hearts.Overweight in mice, induced by perinatal programming, exacerbates doxorubicin and trastuzumab cardiotoxicity.Doxorubicin-induced nitrosative stress is mitigated by vitamin C via the modulation of nitric oxide synthases.MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2.Letter to the editor: "Doxorubicin and ErbB2 overexpression: another piece in the mitochondrial jigsaw".Type IIB DNA topoisomerase is downregulated by trastuzumab and doxorubicin to synergize cardiotoxicity.Doxorubicin conjugated with a trastuzumab epitope and an MMP-2 sensitive peptide linker for the treatment of HER2-positive breast cancer.Investigation of the role of DNA methylation in the expression of ERBB2 in human myocardium.Protective effect of dioscin against doxorubicin-induced cardiotoxicity via adjusting microRNA-140-5p-mediated myocardial oxidative stress.Metformin Mitigates Fibrosis and Glucose Intolerance Induced by Doxorubicin in Subcutaneous Adipose Tissue.Mesenchymal stem cells confer resistance to doxorubicin-induced cardiac senescence by inhibiting microRNA-34a.Perturbation of microRNA signalling by doxorubicin in spermatogonial, Leydig and Sertoli cell lines
P2860
Q26744675-4A602A66-D0E5-498A-B989-8E63193B04AAQ26778666-AFBA648B-C0FE-4C22-95F4-1C8E65941D71Q30276527-6A293659-73A9-4991-A478-2B2FCC170840Q30390384-5BCB8B15-901C-4721-9A50-03B8671C7C7EQ33700084-4E15D45D-9660-4868-AF0E-49E7160FB899Q33720757-BC85098D-3F53-4B48-BF36-7D17D6F0228EQ35681478-E9B82FE1-775F-4C41-BD11-7A574244ED6BQ36085651-9F89718B-63F5-418D-8D3F-D75A79E19879Q36339397-1E0D50AE-4878-4CDB-BED9-DE1DEEECA41DQ37704467-642F886E-1C55-40AE-BE1E-43F9DE7778CBQ38856218-B67739A6-1857-4647-8BD7-F82C07093980Q38974785-88D770E4-301A-48DB-B57A-C67B29528775Q40039502-7D2CAF16-3B53-4BD1-B80E-DD4FCF898661Q41245359-D20E3E3C-A0E8-46D7-A790-820C075D2442Q41810049-9FAF3E95-ED19-4201-A477-3F6D3DAAF956Q42060427-C465AEB5-741B-489A-B43C-A5D2503CDAEAQ42698011-2E14222B-F4E0-485A-99B3-237A078AF76CQ46396418-90A32726-75A7-4040-8E66-C01F922744EFQ46431015-5BD32873-5264-4014-8609-FB65DA2E1B02Q47204916-9964ED07-5035-4DE2-AF7B-54AAB36D92ABQ48228423-A2505391-2069-4207-90EA-BA6A428EBB23Q50060140-653CF18B-DA14-4F4C-AC39-CFFB4BF7AEE6Q50187592-151AA796-9F9E-454E-A8D5-CAB3A2F8B028Q50875570-98F19F6B-83E7-4DFD-BC99-6E18A0CA27AEQ52663010-F2CF0394-B058-4145-8FFB-32F48E1E3EE4Q54977085-75B030B9-9E19-465C-9654-DD3528D4AE9DQ55312032-47398D52-5525-4224-8DC3-155022E929DAQ57497532-C356C8B5-5926-4164-9EE0-B446BE9022BA
P2860
Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms.
@en
type
label
Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms.
@en
prefLabel
Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms.
@en
P2093
P50
P1476
Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms
@en
P2093
Aurélie Gudjoncik
Marianne Zeller
Olivier Hachet
Yves Cottin
P304
P356
10.1016/J.TIPS.2015.03.005
P577
2015-04-17T00:00:00Z